Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-09T03:49:00.997Z Has data issue: false hasContentIssue false

3D printing of poly(ε-caprolactone)/poly(D,L-lactide-co-glycolide)/hydroxyapatite composite constructs for bone tissue engineering

Published online by Cambridge University Press:  27 June 2018

Kazim K. Moncal
Affiliation:
Engineering Science and Mechanics, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA
Dong N. Heo
Affiliation:
Engineering Science and Mechanics, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA
Kevin P. Godzik
Affiliation:
Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802, USA
Donna M. Sosnoski
Affiliation:
Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Department of Biology, Pennsylvania State University, University Park, Pennsylvania 16802, USA
Oliver D. Mrowczynski
Affiliation:
Department of Neurosurgery, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania 17033, USA
Elias Rizk
Affiliation:
Department of Neurosurgery, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania 17033, USA
Veli Ozbolat
Affiliation:
Engineering Science and Mechanics, Pennsylvania State University, University Park, Pennsylvania 16802, USA; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Department of Mechanical Engineering, Ceyhan Engineering Faculty, Cukurova University, Adana 01330, Turkey
Scott M. Tucker
Affiliation:
Engineering Science and Mechanics, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Department of Orthopaedics and Rehabilitation, College of Medicine, Pennsylvania State University, Hershey 17033, Pennsylvania, USA
Ethan M. Gerhard
Affiliation:
Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802, USA
Madhuri Dey
Affiliation:
Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Department of Chemistry, Pennsylvania State University, University Park, Pennsylvania 16802, USA
Gregory S. Lewis
Affiliation:
Engineering Science and Mechanics, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Department of Orthopaedics and Rehabilitation, College of Medicine, Pennsylvania State University, Hershey 17033, Pennsylvania, USA
Jian Yang
Affiliation:
Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA; and Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802, USA
Ibrahim T. Ozbolat*
Affiliation:
Engineering Science and Mechanics, Pennsylvania State University, University Park, Pennsylvania 16802, USA; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park 16802, Pennsylvania, USA; Biomedical Engineering, Pennsylvania State University, University Park 16802, Pennsylvania, USA; and Materials Research Institute, Pennsylvania State University, University Park 16802, Pennsylvania, USA
*
a)Address all correspondence to this author. e-mail: ito1@psu.edu

Abstract

Three-dimensional (3D) printing technology is a promising method for bone tissue engineering applications. For enhanced bone regeneration, it is important to have printable ink materials with appealing properties such as construct interconnectivity, mechanical strength, controlled degradation rates, and the presence of bioactive materials. In this respect, we develop a composite ink composed of polycaprolactone (PCL), poly(D,L-lactide-co-glycolide) (PLGA), and hydroxyapatite particles (HAps) and 3D print it into porous constructs. In vitro study revealed that composite constructs had higher mechanical properties, surface roughness, quicker degradation profile, and cellular behaviors compared to PCL counterparts. Furthermore, in vivo results showed that 3D-printed composite constructs had a positive influence on bone regeneration due to the presence of newly formed mineralized bone tissue and blood vessel formation. Therefore, 3D printable ink made of PCL/PLGA/HAp can be a highly useful material for 3D printing of bone tissue constructs.

Information

Type
Invited Article
Copyright
Copyright © Materials Research Society 2018 
Figure 0

FIG. 1. (a) In-house developed mechanical extrusion system mounted to the MABP29 and its components; (b) thermal images (during extrusion deposition) taken by using a FLIR thermal camera showing typical temperature ranges for PCL printing.

Figure 1

TABLE I. Printing parameters.

Figure 2

TABLE II. Primers of the measured mRNA for RT-PCR.

Figure 3

FIG. 2. (a) TGA and (b) ATR-FTIR results of the ink components, (c) WAXS of crystallinity reflections of PCL and composite inks.

Figure 4

FIG. 3. Temperature dependency of (a) storage modulus (G′) and loss modulus (G″), (b) loss factor for PCL and composite inks, (c) measured complex viscosities from frequency sweep for PCL and (d) composite inks under a temperature range of 50–150 °C.

Figure 5

FIG. 4. (a) Characterization of printed constructs (data presented ± SD); (b) 3D-printed PCL and (c) composite constructs, (d and e) with their SEM images; (f) surface roughness of PCL and composite ink filaments (g) with corresponding RMS (data presented ± SE Mean).

Figure 6

FIG. 5. (a) Ultimate strength and (b) Young’s modulus of 3D-printed PCL and composite constructs; (c) accelerated degradation profile of PCL and composite constructs [# indicates significance (P < 0.01)] with respect to the previous time point in the same group (all data presented ± SD).

Figure 7

FIG. 6. rBMSC-seeded (a) PCL and (b) composite constructs on Day 28; (c) proliferation of seeded rBMSCs on PCL and composite constructs over time; (d) gene expression of ALP (left), OCN (middle), and RUNX2 (right) determined with RT-PCR; immunocytochemistry staining (RUNX2 and BSP) of seeded cells on (e) PCL and (f) composite constructs on Day 28 (all data presented ± SD).

Figure 8

FIG. 7. (a) µCT scan results showing bone tissue regeneration at eight weeks after implantation, (b) BV/TV (%) results, (c) H&E, and (d) CD31 staining of sectioned bone tissue samples for empty defect, PCL and composite constructs (n = 3, all data presented ± SE mean). (NB indicates NB, RB indicates RB, and ST indicates ST. Black arrows indicate deposition of ECM inside the composite filament. White arrows indicate possible vascularization.)